ロード中...
A Critical Evaluation of Neuroprotective and Neurodegenerative MicroRNAs in Alzheimer’s Disease
Currently, 5.4 million Americans suffer from AD, and these numbers are expected to increase up to 16 million by 2050. Despite tremendous research efforts, we still do not have drugs or agents that can delay, or prevent AD and its progression, and we still do not have early detectable biomarkers for...
保存先:
| 出版年: | Biochem Biophys Res Commun |
|---|---|
| 主要な著者: | , , , , , , |
| フォーマット: | Artigo |
| 言語: | Inglês |
| 出版事項: |
2016
|
| 主題: | |
| オンライン･アクセス: | https://ncbi.nlm.nih.gov/pmc/articles/PMC5343756/ https://ncbi.nlm.nih.gov/pubmed/27524239 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1016/j.bbrc.2016.08.067 |
| タグ: |
タグ追加
タグなし, このレコードへの初めてのタグを付けませんか!
|